Author pages are created from data sourced from our academic publisher partnerships and public sources.
Share This Author
Aerobic exercise: effects on parameters related to fatigue, dyspnea, weight and body composition in HIV-infected adults
It is concluded that supervised aerobic exercise training safely decreases fatigue, weight, BMI, subcutaneous fat and abdominal girth (central fat) in HIV-1-infected individuals. Expand
A controlled trial of trimethoprim-sulfamethoxazole or aerosolized pentamidine for secondary prophylaxis of Pneumocystis carinii pneumonia in patients with the acquired immunodeficiency syndrome.…
- W. Hardy, J. Feinberg, +7 authors R. Fass
- The New England journal of medicine
- 24 December 1992
In patients with AIDS who are receiving zidovudine, trimethoprim-sulfamethoxazole is more effective than aerosolized pentamidine in conventional doses for the prevention of recurrent pneumocystis infection. Expand
Bacteremia With Streptococcus pneumoniae: Implications for Therapy and Prevention
Increased use of pneumococcal vaccine and recognition of antimicrobial resistance patterns may assist physicians in treating patients withS pneumoniaebacteremia. Expand
Neuropsychological performance in symptomatic and asymptomatic HIV infection.
Examination of cognitive function in patients at various stages of HIV infection indicates that there is a steady increase in the prevalence of neurobehavioral abnormalities associated with stage of infection and the pattern of abnormality also varies with disease stage. Expand
In vitro activity of Bay 12-8039, a new 8-methoxyquinolone
- R. Fass
- Medicine, Biology
- Antimicrobial agents and chemotherapy
- 1 August 1997
There was a high degree of correlation among quinolone MICs, and Bay 12-8039 was approximately 2- to 16-fold more active than ciproiloxacin and ofloxac in against nonfermenters (except P. aeruginosa), staphylococci, streptococci), enterococci and anaerobes. Expand
In Vitro Activity of LY127935
- R. Fass
- Medicine, Biology
- Antimicrobial Agents and Chemotherapy
- 1 October 1979
The broad spectrum and marked in vitro activity of LY127935 make it a promising new antibiotic. Expand
The safety and efficacy of combination N-butyl-deoxynojirimycin (SC-48334) and zidovudine in patients with HIV-1 infection and 200-500 CD4 cells/mm3.
- M. Fischl, L. Resnick, +7 authors R. L. Aspinall
- Journal of acquired immune deficiency syndromes
- 1 February 1994
Diarrhea, flatulence, abdominal pain, and weight loss were common for combination recipients and the mean SC-48334 steady-state trough level was below the in vitro inhibitory concentration for human immunodeficiency virus (HIV). Expand
In vitro susceptibilities of Aeromonas hydrophila to 32 antimicrobial agents
Minimal inhibitory concentrations of 32 antimicrobial agents for 20 strains fo Aeromonas hydrophila were determined by a microdilution method. Moxalactam was the most active drug tested. All strains… Expand
Central nervous system toxicity associated with metronidazole therapy.
Excerpt Metronidazole is a nitroimidazole compound best known as an antimicrobial agent for treating infections caused by susceptible protozoa and anaerobic bacteria. Neurologic side effects attrib...
Revised interpretation of oxacillin MICs for Staphylococcus epidermidis based on mecA detection
Current National Committee for Clinical Laboratory Standards MIC interpretive criteria may underestimate methicillin resistance among S. epidermidis strains. Expand